Clinical trial
A Study of the Effectiveness and Safety of Ramipril in the Treatment of…
NCT00389519 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00389519 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Arm Study Assessing the Efficacy, Safety, and Dose-Response of Ramipril for the Treatment of Hypertension in Children and Adolescents |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | ramipril, placebo |
| Enrollment | 422 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Oct 19, 2006 |
| Last update posted | Jun 11, 2012 |
| Countries | Argentina, Chile, Colombia, India, Poland, South Africa, Turkey (Türkiye), Ukraine, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: